Autifony Therapeutics wins Best Emerging Biotech Award at OBN Awards Dinner

2 October 2013

London – UK – 2nd October 2013 – Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for hearing disorders and serious disorders of the nervous system, announced that it was awarded the prize for Best Emerging Biotech at the OBN Annual Awards Dinner on 1^st October.